Olivia O'Leary

606 total citations · 1 hit paper
9 papers, 460 citations indexed

About

Olivia O'Leary is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Olivia O'Leary has authored 9 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Olivia O'Leary's work include Retinal Diseases and Treatments (3 papers), Retinal and Optic Conditions (2 papers) and Retinal Imaging and Analysis (2 papers). Olivia O'Leary is often cited by papers focused on Retinal Diseases and Treatments (3 papers), Retinal and Optic Conditions (2 papers) and Retinal Imaging and Analysis (2 papers). Olivia O'Leary collaborates with scholars based in United Kingdom, Switzerland and United States. Olivia O'Leary's co-authors include Alan W. Stitt, Judith Lechner, David Goldblum, Andreas Schoetzau, Paul Jenoe, Beatrice Drexler, Sarah McLoughlin, Suzette Moes, Nadine Gerber-Hollbach and Breandán N. Kennedy and has published in prestigious journals such as PLoS ONE, Vision Research and Investigative Ophthalmology & Visual Science.

In The Last Decade

Olivia O'Leary

8 papers receiving 450 citations

Hit Papers

The pathology associated with diabetic retinopathy 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia O'Leary United Kingdom 6 277 169 153 53 46 9 460
Zhilan Yuan China 13 223 0.8× 136 0.8× 196 1.3× 51 1.0× 46 1.0× 33 509
Stephanie Loomis United States 12 387 1.4× 164 1.0× 149 1.0× 47 0.9× 47 1.0× 25 654
Carlo Gesualdo Italy 16 316 1.1× 140 0.8× 307 2.0× 44 0.8× 56 1.2× 35 655
Chufeng Gu China 11 161 0.6× 103 0.6× 217 1.4× 27 0.5× 29 0.6× 35 420
Bertan Cakir United States 16 347 1.3× 260 1.5× 224 1.5× 27 0.5× 21 0.5× 28 605
Yuzhi Ding China 9 197 0.7× 110 0.7× 221 1.4× 36 0.7× 34 0.7× 20 410
Faryan Tayyari United States 14 236 0.9× 140 0.8× 174 1.1× 37 0.7× 38 0.8× 17 463
Eric Jablon United States 6 241 0.9× 137 0.8× 136 0.9× 21 0.4× 44 1.0× 8 424
Rasa Liutkevičienė Lithuania 13 285 1.0× 147 0.9× 200 1.3× 32 0.6× 24 0.5× 122 612

Countries citing papers authored by Olivia O'Leary

Since Specialization
Citations

This map shows the geographic impact of Olivia O'Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia O'Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia O'Leary more than expected).

Fields of papers citing papers by Olivia O'Leary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia O'Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia O'Leary. The network helps show where Olivia O'Leary may publish in the future.

Co-authorship network of co-authors of Olivia O'Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia O'Leary. A scholar is included among the top collaborators of Olivia O'Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia O'Leary. Olivia O'Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Barakat, Mark, et al.. (2025). Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe. Clinical ophthalmology. Volume 19. 395–406.
2.
O'Leary, Olivia, Andreas Schoetzau, Paul Jenoe, et al.. (2020). Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification. Translational Vision Science & Technology. 9(9). 3–3. 15 indexed citations
3.
Canning, Paul, et al.. (2019). ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators.. Investigative Ophthalmology & Visual Science. 60(9). 2720–2720. 1 indexed citations
4.
O'Leary, Olivia, Paul Canning, Emma Reid, et al.. (2019). The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic. Experimental Eye Research. 182. 144–155. 16 indexed citations
5.
Gerber-Hollbach, Nadine, Olivia O'Leary, Paul Jenoe, et al.. (2018). Tear Film Proteomics Reveal Important Differences Between Patients With and Without Ocular GvHD After Allogeneic Hematopoietic Cell Transplantation. Investigative Ophthalmology & Visual Science. 59(8). 3521–3521. 23 indexed citations
6.
Lechner, Judith, Olivia O'Leary, & Alan W. Stitt. (2017). The pathology associated with diabetic retinopathy. Vision Research. 139. 7–14. 369 indexed citations breakdown →
7.
O'Leary, Olivia, Emma Reid, Carmel McVicar, et al.. (2013). A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair. Investigative Ophthalmology & Visual Science. 54(15). 4619–4619. 1 indexed citations
8.
Yin, Jun, Alison Reynolds, Kristin Ackerman, et al.. (2012). Inhibition of the Pim1 Oncogene Results in Diminished Visual Function. PLoS ONE. 7(12). e52177–e52177. 18 indexed citations
9.
McLoughlin, Sarah, Lynne C. O’Shea, Olivia O'Leary, et al.. (2011). Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a -/- mutants. BMC Developmental Biology. 11(1). 71–71. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026